Page last updated: 2024-08-24

fosinoprilat and captopril

fosinoprilat has been researched along with captopril in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's4 (44.44)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cushman, DW; DeForrest, JM; Duggan, M; Karanewsky, DS; Krapcho, J; Powell, JR; Rovnyak, G; Schwartz, J; Spitzmiller, ER; Turk, C1
Lombardo, F; Obach, RS; Waters, NJ1
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M1
Cushman, DW; Dzwonczyk, S; Fung, W; Grover, GJ; Sleph, PG; Tobias, D; Wang, P1
Abboa-Offei, B; Seymour, AA; Swerdel, JN1
Cushman, DW; DeForrest, JM; Harvey, C; Petrillo, EW; Powell, JR; Rubin, B; Scalese, B; Waldron, TL1
Mackaness, GB1
Baker, JR; Bigby, TD; Kylstra, TA1
Abu Hasan, Z'; Acharya, KR; Cozier, GE; Isaac, RE; Ismail, NM; Othman, H; Williams, H1

Other Studies

9 other study(ies) available for fosinoprilat and captopril

ArticleYear
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Enalaprilat; Kinetics; Male; Phosphinic Acids; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1988
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents

1992
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Drug Stability; Enalaprilat; Fosinopril; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Prodrugs; Proline; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds

1991
Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:3

    Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fosinopril; Hypertension; Male; Neprilysin; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sulfhydryl Compounds

1991
Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:5

    Topics: Acute Kidney Injury; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dogs; Fosinopril; Heart Rate; Injections, Intravenous; Macaca fascicularis; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Time Factors

1989
The future of angiotensin-converting enzyme inhibitors.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding Sites; Captopril; Diuretics; Fosinopril; Humans; Intestinal Absorption; Kinetics; Organophosphorus Compounds; Renin; Snake Venoms; Zinc

1985
Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
    Biochemical pharmacology, 1995, Sep-28, Volume: 50, Issue:7

    Topics: Aminopeptidases; Captopril; Cell Line; Cell-Free System; Epithelium; Epoxide Hydrolases; Fosinopril; Humans; Kinetics; Leucine; Leukotriene B4; Metalloendopeptidases; Neutrophils; Protease Inhibitors

1995
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.
    Scientific reports, 2017, 03-27, Volume: 7

    Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Captopril; Disease Vectors; Fosinopril; Humans; Insecticide Resistance; Insecticides; Larva; Mosquito Vectors; Peptidyl-Dipeptidase A

2017
chemdatabank.com